Enzymology of bioreductive drug activation. - Wikidata - awgldk - TriplyDB

Enzymology of bioreductive drug activation.

Enzymology of bioreductive drug activation.

http://www.wikidata.org/entity/Q41078518

about

The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone Implications of NQO1 in cancer therapy Applications of azo-based probes for imaging retinal hypoxia.Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantrone Synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity.Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action.In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme.Flavoenzyme-mediated reduction reactions and antitumor activity of nitrogen-containing tetracyclic ortho-quinone compounds and their nitrated derivatives.Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.

P2860

Q24796330-8AD239E9-69D4-4164-85E4-CBCB8BCF9057 Q26783702-64B0DFD4-029D-4C2A-A7F6-E6FCBA438BFA Q35379084-1F5389D1-DED8-47DB-B1EF-D9A9F7049523 Q36573248-7D20D9F1-3C49-4BCB-8142-DBD0DCF25833 Q36876799-4DD42B17-9C25-4C63-A8D3-CDE729E01BB6 Q36953062-2C7BDF73-8E59-40AB-BA39-2D31286D7A7A Q37153715-A72F8934-36F8-4008-BD1E-768C4388BFB2 Q37444754-613581BC-26CD-46CB-A5D0-3B285A5477E0 Q37692717-9167B494-C3D6-44F5-A82F-EE7655F58623 Q40996112-32BB5756-D8AE-4E86-8D80-23EDDB792037 Q41680794-AAC83C4A-E57C-48AF-8EEE-D4AF8AAD8EF8

P2860

Enzymology of bioreductive drug activation.

http://www.wikidata.org/entity/Q41078518

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

1996年學術文章

@zh

1996年學術文章

@zh-hant

name

Enzymology of bioreductive drug activation.

@en

type

label

Enzymology of bioreductive drug activation.

@en

prefLabel

Enzymology of bioreductive drug activation.

@en

P1433

Q41078518-0BCDEFE9-5C69-497D-8CC2-1F2D2920B308

P1476

Q41078518-0820F1C6-BA86-45ED-8A00-D34A75668FAF

P2093

Q41078518-1630DC0C-7AEF-46C4-882A-A97FCDDA6F2F

Q41078518-AAF6467C-7324-413C-8DBF-433F9C84E943

Q41078518-D8895E23-0F2F-406B-AD85-A7B897A8C8AF

Q41078518-DBD8AA31-E929-45E8-893E-8E49E8687C78

Q41078518-DCA88324-BF1B-4C23-BA46-E13B462F4307

P2860

Q41078518-046491F4-DA5F-4420-858A-F10DFB4E5F31

Q41078518-06C7DB13-92F9-4D99-8D8A-948EC67A0228

Q41078518-0E07146C-3A78-4AD2-9C18-DBA2A9686D9F

Q41078518-0F54A117-52D2-4504-9A1E-A495194368DA

Q41078518-21441723-4451-4A01-A631-49A4AA8F1920

Q41078518-2B8B0E48-94E0-418C-A8A8-E391D05CA975

Q41078518-2F1B61C8-3208-4BD3-BD08-24DA5F7D021B

Q41078518-32AE2A91-6CD6-4056-86A9-409CDD1CC559

Q41078518-34E61371-C0A6-41B3-B0DA-8912830A6940

Q41078518-37BF57E2-C2EA-4C0D-ACB8-057E7689FA93

P304

Q41078518-7A68EA33-9B49-445A-A7D5-8BDF652B97F8

P31

Q41078518-596DA7AF-F86D-421B-B8CB-D397968E2CB8

P478

Q41078518-8D8EDF8B-3D8B-41EC-8F39-0EFEB7E8FAD1

P577

Q41078518-D64CFA3E-A946-4BB0-B540-C132D09B8F55

P698

Q41078518-CF7DDD6E-98B3-43ED-B07C-CC47DB0004A9

P932

Q41078518-370CE7AA-5ABB-4468-AB26-E47FC33386FB

P1433

The British Journal of Cancer. Supplement

P1476

Enzymology of bioreductive drug activation.

@en

P2093

D L Gustafson

http://www.w3.org/2001/XMLSchema#string

D Ross

http://www.w3.org/2001/XMLSchema#string

D Siegel

http://www.w3.org/2001/XMLSchema#string

H D Beall

http://www.w3.org/2001/XMLSchema#string

R D Traver

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6

Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16

Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity

Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity

Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells

DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Effect of substituents on autoxidation rates

Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.

DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.

Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions

P304

S1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8763836

http://www.w3.org/2001/XMLSchema#string

P932

2150032

http://www.w3.org/2001/XMLSchema#string